news
STAT News questions over-dosing in cancer drug trials
STAT News reported that many cancer drug trials might be using doses far higher than necessary. This practice could be causing severe side effects, impacting patients' quality of life and potentially even treatment effectiveness. It's a call for pharmaceutical companies to re-evaluate how they set drug dosages.
STAT News reported that many cancer drug trials might be using doses far higher than necessary. This practice could be causing severe side effects, impacting patients' quality of life and potentially even treatment effectiveness. It's a call for pharmaceutical companies to re-evaluate how they set drug dosages.
The architecture take
I read this and immediately wondered how many other medications are over-dosed because it's easier than finding the minimum effective amount. For oncology drugs, the thinking was always 'more is better,' trying to hit the maximum tolerated dose. But it turns out 'tolerated' doesn't mean 'optimal.' Patients are getting slammed with side effects like fatigue, nausea, neuropathy, and brain fog — all the things that directly mess with your nervous system and quality of life. Pharma often doesn't want to fund trials to find a lower, effective dose because it's expensive and doesn't always boost market share. This isn't just about cancer care; it's about our bodies handling the chemical load we give them. When we talk about finding your personal baseline for supplements or even caffeine, it's the same principle. I want to see more research funded specifically to pinpoint the least amount of a drug that still does the job. That's real precision.